ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, dysregulation of intracellular BMP signaling mediated by BCR-ABL corrupts and amplifies the response to exogenous morphogens released by the niche, which are abnormally abundant and directly influence CSC fate.